decisionhealth Newsletters, Part B News - 2007 Issue 3 (March)
Compound, unit Albuterol top April drug price changes
Subscribe or sign in to view the full article.
Article Overview
This article covers CMS’s quarterly update to Medicare Part B drug reimbursement under the average sales price methodology, with emphasis on April 1, 2007 price changes. It is relevant for coders, billing staff, and reimbursement professionals who track drug payment trends, utilization, and pricing shifts across commonly billed injectable and oral drugs. The article also presents a ranked summary of selected drugs with the largest payment increases and decreases during the update period.
Why This Topic Matters
Quarterly ASP changes can affect reimbursement forecasting, charge capture, and payment monitoring for high-volume Part B drugs. Understanding which drugs moved most helps billing and finance teams stay current on reimbursement trends and prepare for effective-date changes.
What You Will Learn
- How CMS quarterly Part B drug pricing updates can change reimbursement amounts
- Which broad categories of drugs saw notable payment increases or decreases
- How the article frames the impact of ASP-based pricing changes on commonly billed drugs
- Which high-level payment trends were observed for the April 2007 update
Who Should Read This
- Medical coders
- Billing staff
- Reimbursement specialists
- Practice managers
- Revenue cycle professionals
- Pharmacy billing teams
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com